FI940378A0 - 5-membered heterocycles, process for their preparation and drugs containing these compounds - Google Patents

5-membered heterocycles, process for their preparation and drugs containing these compounds

Info

Publication number
FI940378A0
FI940378A0 FI940378A FI940378A FI940378A0 FI 940378 A0 FI940378 A0 FI 940378A0 FI 940378 A FI940378 A FI 940378A FI 940378 A FI940378 A FI 940378A FI 940378 A0 FI940378 A0 FI 940378A0
Authority
FI
Finland
Prior art keywords
compounds
preparation
membered heterocycles
drugs containing
drugs
Prior art date
Application number
FI940378A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI940378A (en
Inventor
Guenter Linz
Frank Himmelsbach
Volkhard Austel
Helmut Pieper
Thomas Mueller
Johannes Weisenberger
Brian Guth
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of FI940378A0 publication Critical patent/FI940378A0/en
Publication of FI940378A publication Critical patent/FI940378A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
FI940378A 1993-01-26 1994-01-26 5-membered heterocycles, process for their preparation and drugs containing these compounds FI940378A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4302051A DE4302051A1 (en) 1993-01-26 1993-01-26 5-membered heterocycles, process for their preparation and medicaments containing these compounds

Publications (2)

Publication Number Publication Date
FI940378A0 true FI940378A0 (en) 1994-01-26
FI940378A FI940378A (en) 1994-07-27

Family

ID=6478937

Family Applications (1)

Application Number Title Priority Date Filing Date
FI940378A FI940378A (en) 1993-01-26 1994-01-26 5-membered heterocycles, process for their preparation and drugs containing these compounds

Country Status (18)

Country Link
EP (1) EP0608858A1 (en)
JP (1) JPH072851A (en)
KR (1) KR940018382A (en)
CN (1) CN1097753A (en)
AU (1) AU5398494A (en)
BG (1) BG98409A (en)
CA (1) CA2114178A1 (en)
CZ (1) CZ18194A3 (en)
DE (1) DE4302051A1 (en)
FI (1) FI940378A (en)
HU (1) HU9400217D0 (en)
IL (1) IL108436A0 (en)
NO (1) NO940261L (en)
NZ (1) NZ250762A (en)
PL (1) PL302018A1 (en)
RU (1) RU94002482A (en)
SK (1) SK8394A3 (en)
ZA (1) ZA94495B (en)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5849736A (en) * 1993-11-24 1998-12-15 The Dupont Merck Pharmaceutical Company Isoxazoline and isoxazole fibrinogen receptor antagonists
ZA963391B (en) * 1995-05-24 1997-10-29 Du Pont Merck Pharma Isoxazoline fibrinogen receptor antagonists.
CA2229617A1 (en) * 1995-10-20 1997-05-01 Dr. Karl Thomae Gmbh 5-membered heterocycles, medicaments containing these compounds, their use and processes for their preparation
US6083986A (en) * 1996-07-26 2000-07-04 Icagen, Inc. Potassium channel inhibitors
US6333337B1 (en) 1998-01-27 2001-12-25 Icagen, Inc. Potassium channel inhibitors
PL345247A1 (en) 1998-07-01 2001-12-03 Takeda Chemical Industries Ltd Retinoid-associated receptor regulators
WO2000047188A1 (en) * 1999-02-11 2000-08-17 Emisphere Technologies, Inc. Oxadiazole compounds and compositions for delivering active agents
US7084279B1 (en) 1999-02-11 2006-08-01 Emisphere Technologies Inc. Oxadiazole compounds and compositions for delivering active agents
EP1240147A1 (en) 1999-12-21 2002-09-18 Icagen, Inc. Potassium channel inhibitors
AU2000223275A1 (en) * 2000-02-08 2001-08-20 Yamanouchi Pharmaceutical Co..Ltd. Novel triazole derivatives
WO2001087855A1 (en) * 2000-05-19 2001-11-22 Yamanouchi Pharmaceutical Co., Ltd. Triazole derivatives
US6566380B2 (en) 2000-07-25 2003-05-20 Icagen, Inc. Potassium channel inhibitors
US6620849B2 (en) 2000-07-26 2003-09-16 Icafen, Inc. Potassium channel inhibitors
US6849634B2 (en) 2000-12-21 2005-02-01 Icagen Potassium channel inhibitors
US7223791B2 (en) * 2001-06-26 2007-05-29 Takeda Pharmaceutical Company Limited Function regulator for retinoid relative receptor
US7390813B1 (en) 2001-12-21 2008-06-24 Xenon Pharmaceuticals Inc. Pyridylpiperazines and aminonicotinamides and their use as therapeutic agents
AU2003218028A1 (en) 2002-03-08 2003-09-22 Bristol-Myers Squibb Company Cyclic derivatives as modulators of chemokine receptor activity
JP4926402B2 (en) 2002-11-27 2012-05-09 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド 1,2,3-Triazoleamide derivatives as cytokine inhibitors
US7078419B2 (en) 2003-03-10 2006-07-18 Boehringer Ingelheim Pharmaceuticals, Inc. Cytokine inhibitors
BRPI0409686A (en) 2003-04-24 2006-07-04 Incyte Corp aza spiro alkane derivatives as metalloprotease inhibitors
EP2316827B1 (en) 2003-07-30 2016-01-27 Xenon Pharmaceuticals Inc. Piperazine derivatives and their use as therapeutic agents
ES2360292T3 (en) 2003-12-03 2011-06-02 Boehringer Ingelheim Pharmaceuticals Inc. 1,2,3-TRIAZOL AMIDA DERIVATIVES AS INHIBITORS OF CYTOKIN PRODUCTION.
PT1725544E (en) 2004-03-09 2009-07-02 Boehringer Ingelheim Pharma 3-[4-heterocyclyl-1,2,3-triazol-1-yl]-n-aryl-benzamides as inhibitors of the cytokines production for the treatment of chronic inflammatory diseases
WO2005108387A2 (en) 2004-05-03 2005-11-17 Boehringer Ingelheim Pharmaceuticals, Inc. Cytokine inhibitors
US7485657B2 (en) 2004-05-12 2009-02-03 Boehringer Ingelheim Pharmaceuticals, Inc. Anti-cytokine heterocyclic compounds
EP2269610A3 (en) 2004-09-20 2011-03-09 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
CA2580845A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase
MX2007003318A (en) 2004-09-20 2007-05-18 Xenon Pharmaceuticals Inc Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes.
BRPI0515488A (en) 2004-09-20 2008-07-29 Xenon Pharmaceuticals Inc heterocyclic derivatives and their use as therapeutic agents
AU2005286647A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
CN101084207A (en) 2004-09-20 2007-12-05 泽农医药公司 Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
MX2007003327A (en) 2004-09-20 2007-06-05 Xenon Pharmaceuticals Inc Heterocyclic derivatives and their use as mediators of stearoyl-coa desaturase.
US7531560B2 (en) 2004-11-10 2009-05-12 Boehringer Ingelheim Pharmaceuticals, Inc. Anti-cytokine heterocyclic compounds
AP2007004047A0 (en) 2005-01-20 2007-06-30 Pfizer Ltd Substituted triazole derivatives as oxtocin antagonists
JP2009513563A (en) 2005-06-03 2009-04-02 ゼノン・ファーマシューティカルズ・インコーポレイテッド Aminothiazole derivatives as human stearoyl-CoA desaturase inhibitors
TW200811164A (en) * 2006-05-12 2008-03-01 Jerini Ag New heterocyclic compounds for the inhibition of integrins and use thereof
US7910108B2 (en) 2006-06-05 2011-03-22 Incyte Corporation Sheddase inhibitors combined with CD30-binding immunotherapeutics for the treatment of CD30 positive diseases
TW200813018A (en) 2006-06-09 2008-03-16 Astrazeneca Ab Novel compounds
RU2009110254A (en) 2006-08-24 2010-09-27 Новартис АГ (CH) 2- (PYRAZIN-2-IL) THIAZOLE DERIVATIVES AND 2- (1H-PYRAZOL-3-IL) THYRAZOL AND COMPOUNDS CONNECTED WITH IT AS STEAROIL-SOA INHIBERATOUS AND SMOKE
PL2090570T3 (en) 2006-09-05 2012-03-30 Kyowa Hakko Kirin Co Ltd Imidazole derivative
CA2685266C (en) 2007-04-27 2014-01-28 Purdue Pharma L.P. Trpv1 antagonists and uses thereof for the treatment of prevention of pain, ui and ulcer, ibd, or ibs in an animal
US8119661B2 (en) 2007-09-11 2012-02-21 Astrazeneca Ab Piperidine derivatives and their use as muscarinic receptor modulators
CA2801074A1 (en) 2010-06-04 2011-12-08 Albany Molecular Research, Inc. Glycine transporter-1 inhibitors, methods of making them, and uses thereof
EP2723732B1 (en) 2011-06-22 2017-01-18 Purdue Pharma LP Trpv1 antagonists including dihydroxy substituent and uses thereof
US9593106B2 (en) 2013-02-07 2017-03-14 Heptares Therapeutics Limited Piperidin-1-yl and azepin-1-yl carboxylates as muscarinic M4 receptor agonists
GB201810071D0 (en) 2018-06-19 2018-08-08 Univ Oslo Hf Compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL98757A (en) * 1990-07-18 1997-01-10 Novo Nordisk As Piperidine derivatives their preparation and pharmaceutical compositions containing them
DE4124942A1 (en) * 1991-07-27 1993-01-28 Thomae Gmbh Dr K 5-LOW HETEROCYCLES, METHOD FOR THE PRODUCTION THEREOF AND MEDICAMENTS CONTAINING SUCH COMPOUNDS

Also Published As

Publication number Publication date
CA2114178A1 (en) 1994-07-27
CZ18194A3 (en) 1994-11-16
DE4302051A1 (en) 1994-07-28
NO940261D0 (en) 1994-01-25
CN1097753A (en) 1995-01-25
EP0608858A1 (en) 1994-08-03
BG98409A (en) 1994-09-30
HU9400217D0 (en) 1994-05-30
ZA94495B (en) 1995-07-25
AU5398494A (en) 1994-08-04
IL108436A0 (en) 1994-04-12
PL302018A1 (en) 1994-08-08
FI940378A (en) 1994-07-27
NZ250762A (en) 1995-08-28
KR940018382A (en) 1994-08-16
RU94002482A (en) 1996-08-27
NO940261L (en) 1994-07-27
SK8394A3 (en) 1995-02-08
JPH072851A (en) 1995-01-06

Similar Documents

Publication Publication Date Title
FI940378A0 (en) 5-membered heterocycles, process for their preparation and drugs containing these compounds
EP0525629A3 (en) 5-membered heterocycles, process for their preparation and medicaments containing them
FI943579A (en) Benzo-condensed heterocyclic compounds with 5-membered ring, process for their preparation, their use as drugs, their use as diagnostics and drugs containing said compounds
FI940697A0 (en) Condensed 5-membered heterocycles, process for their preparation and drugs containing these compounds
NO944700D0 (en) New Thienothiazine Derivatives, Process for their Preparation and Pharmaceutical Preparations Containing the Compounds
NO973479L (en) Substituted heterocyclic compounds, method of preparation and pharmaceutical compositions containing the same
ZA926700B (en) Condensed 5-membered heterocyclic compounds processes for preparing them and pharmaceutical preparations containing these compounds
EE9700043A (en) Substituted oxazolidinones, process for their preparation, use in the manufacture of medicaments and medicaments containing these compounds
EE03177B1 (en) Heterobicyclic compounds, methods for their preparation and pharmaceutical compositions containing said compounds
HUT72308A (en) Thiazolidine derivatives and pharmaceutical composition containing the same, and process for their preparation
NO933248D0 (en) Cyclic urea derivatives, drugs containing these compounds, and processes for their preparation
HUP9901159A3 (en) Substituted benzylaminopiperidine derivatives and use thereof, pharmaceutical compositions containing these compounds
FI954767A (en) Lopophilic drugs containing pharmaceutical composition
EE9700019A (en) 2-Oxo- and 2-thio-1,2-dihydroquinolinyloxazolidinones, process for their preparation, use in the manufacture of medicaments and medicaments containing these compounds
NO932636D0 (en) BENZIMIDAZOLES, MEDICATIONS CONTAINING THESE COMPOUNDS, AND PROCEDURE FOR THEIR PREPARATION
DK114189A (en) BENZOCYCLOHEPTENDER DERIVATIVES, AND MEDICINAL PRODUCTS CONTAINING SUCH COMPOUNDS
FI935654A (en) Condensed heterocyclic compounds, their preparation and use
EP0572308A3 (en) Heterocyclic derivatives, process for their preparation and pharmaceutical compositions containing them.
BR9202327A (en) HETEROCYCLIC COMPOUND, PROCESS FOR ITS PREPARATION, PHARMACEUTICAL PREPARATION AND PROCESS FOR ITS PREPARATION
NO913162D0 (en) PHARMACEUTICAL PREPARATION FOR TONSILLITE TREATMENT.
NO933558D0 (en) BENZIMIDAZOLES, PHARMACEUTICALS CONTAINING THESE COMPOUNDS, AND PROCEDURE FOR THEIR PREPARATION
EE9600021A (en) Substituted indole derivatives, process for their preparation, use in the manufacture of medicaments, medicaments containing these compounds and a process for their preparation
AU1417592A (en) Heterocyclic compounds, their preparation and pharmaceutical use
FI972129A0 (en) 6-Methoxy-1H-benzotriazole-5-carboxamide derivatives, process for their preparation and pharmaceutical compositions containing them
HRP950267A2 (en) Heterocyclic compounds, pharmaceutical preparations containing them and the preparation thereof

Legal Events

Date Code Title Description
FD Application lapsed